The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours G. Kovacs OriginalPaper Pages: 64 - 68
The use of molecular genetic analysis in the diagnosis of renal cell carcinoma J. P. LongP. AnglardW. M. Linehan OriginalPaper Pages: 69 - 73
Molecular biologic investigations of proto-oncogenes and growth factors in human testicular tumors T. Strohmeyer OriginalPaper Pages: 74 - 78
P53 accumulation in precursor lesions and early stages of bladder cancer B. J. Schmitz-DrägerC. R. C. van RoeyenR. Ackermann OriginalPaper Pages: 79 - 83
Molecular prognostic factors in bladder cancer J. A. M. VetF. M. J. DebruyneJ. A. Schalken OriginalPaper Pages: 84 - 88
Bladder cancer: the molecular progression to invasive disease A. R. SimoneauP. A. Jones OriginalPaper Pages: 89 - 95
Differential expression of transforming growth factor-β1 and β3 as well as C-FOS mRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancer V. W. MerzA. M. ArnoldU. E. Studer OriginalPaper Pages: 96 - 98
Androgen signal transduction and prostatic carcinoma H. KlockerZ. CuligG. Bartsch OriginalPaper Pages: 99 - 103
From laboratory expertise to clinical practice: multidrug-resistance-based gene therapy becomes available for urologists G. H. MickischF. H. Schroeder OriginalPaper Pages: 104 - 111